Terminal differentiation of hematopoietic cells follows a precisely orchestrated program of transcriptional regulatory events at the promoters of both lineage-specific and ubiquitous genes. Here we show that the transcription factor ATF2 is associated with the induction of granulocytic differentiation and the molecular interaction of ATF2 wih a tissue-specific coactivator coactivator activating signal cointegator-2 (ASC-2) potentiates the differentiation procedure. All-trans retinoic acid (RA) induced the phosphorylation and expression of ATF2 in the early and middle phase of granulocyte differentiation, respectively. The activation of granulocyte-specific gene expression is increased with the concerted action of another bZIP factor, C/EBP , and ASC-2, which function in a cooperative manner. The interaction between ATF2 and C/EBP in RA-treated cells was enhanced by the ectopic expression of ASC-2. ATF2-mediated transactivation was also increased by cotransfection of ASC-2. This resulted from the direct protein interaction that the Nterminal transactivation domain of ATF2 interacts with the central region of ASC-2.
INTRODUCTION
The pluripotent blood stem cells mature by transcription factors that activate lineage-specific genes are essential to the commitment and development of specific hematopoietic lineages, erythroid, myeloid or lymphoid cells (1) . The vitamin A metabolite, all-trans retinoic acid (AtRA), induces the granulocytic differentiation of the promyelocytic cell line U937, similar to HL60. C/EBP , C/EBP and PU.1 etc.
have been known to contribute in granulopoiesis (2) . Especially C/EBP is essential to granulocyte differentiation in an early stage and in vitro forms a heterodimeric DNA binding complex with another transcription factors of the bzip family, ATF-2 in liver cells (3) .
Among ATF/CREB family, ATF2 (initially called CRE-BP1, 4-5) as been more extensively studied and shown to be ubiquitously expressed with the highest level of expression being observed in the brain. A common characteristic of these factors is the presence of a transcriptional activation domain containing the metal finger structure located in the amino-terminal region and basic region-leucine zipper (bZIP) proteins in the carboxy-terminal region (6) . ATF2 is capable of forming homodimers or heterodimers with c-Jun for binding to CRE (5'-TGACGTCA-3') (6) . Especially, ATF2 is known to play an important role in inducing cell differentiation including cardiomyocyte (7) , adipogenesis in early stage (8) and central nervous system development (9) . Some cofactors, structural modification and phosphorylation were known to influence on transcriptional activation of ATF2. For example, TIP49b was reported as a regulator of ATF2 response to stress and DNA damage (10) . ATF2 exhibits intramolecular inhibitory interaction between N-terminal transactivation domain and C-terminal DNA binding domain under normal growth condition (11) . Stability, transcriptional activity and histone acetyltransferase (HAT) activity of the ATF2
To stimulate transcriptional activity of specific transcription factors, the cooperative association of transcriptional coactivator, CBP/p300, was necessary.
Previously, we elicited that differentiation-dependent expressed ASC-2 protein physically and functionally interacts with C/EBP and increases its transactivation activity in granulocyte differentiation (21). Lee et al. isolated a novel coactivator ASC-2 by using retinoid X receptor (RXR) as a bait (22). ASC-2 was also subsequently identified from several groups as named RAP250, PRIP, and TRBP (23-25) and also identical to AIB-3, which was amplified in breast and other human cancers (26). ASC-2, a typical ligand-and AF2-dependent interactor of nuclear receptors, enhances the receptor transactivation, either alone or in conjunction with SRC-1 and CBP/p300 and functionally interacted with specific transcription factors including PPAR , TR, NF-B, AP-1, and serum response factor (SRF) (27).
To understand the process of normal myeloid differentiation, it is important to identify and characterize the transcription factors that specifically activate important genes in the myeloid lineage. Until now, it is wholly lacking that ATF2 is involved in hematopietic differentiation. But we already reported that retinoic Acid activates the p38 kinase pathway leading to phosphorylation and activation of ATF-2, thereby enhancing PEPCK gene transcription and glucose production (20). Therefore, this reflects the indirect evidence that ATF2 may be related in granulocyte differentiation.
In this study, we show two novel points that ATF2 is required for the induction of granulocytic differentiation and associates with granulocyte-specific transcription factor C/EBP by RA treatment and the ASC-2 functions as a coactivator for ATF2 in the differentiation process. These results support that the ganulocytic differention requires a specific transcription factor-regulated cascade action including a variety of specific transcrition factors and coactivators.
HeLa and U937 cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% heat-inactivated fetal bovine serum (FBS) (Gibco BRL) and 1% antibiotics. The cells were seeded in 24-well plates with growth medium and co-transfected with pRSV/ -gal vector and expression vectors for ASC-2 and/or ATF-2 by using superfect (Qiagen corp) or electroporation. Total amounts of expression vectors were kept constant by adding pcDNA3.1/His C. Relative luciferase and -galactosidase activities were determined as described (28). All the transfection results represent the mean of three independent experiments. For establishment of the N-terminal domain ATF2 (ATF2-N)-expressing stable cell line, HeLa cells were transfected with 3 g of ATF2-N expression plasmid (pcDNA3/HA) using calcium phosphate co-precipitation method with BES. At 48 hr posttransfection, cells were cultured in the presence of 500 g/ml G418 (GIBCO BRL).
After 21 days in selective medium, individual G418-resistant colonies were isolated.
Glutathione S-transferase (GST) pull-down assay between ASC-2 and ATF2
GST-fusion proteins were purified as described previously. Equal amounts 
Identification of the protein-protein interaction of ATF2 and ASC-2 and each interacting region
The association between ATF2 and ASC-2 was characterized by co- 
RA potentiates the physical association of ATF2 and C/EBP in granulocytic differentiation
The results shown in Fig. 4 indicate that the temporally increased coactivator increases the association of ATF2 and C/EBP . The ASC-2 expression was induced in the process of RA-dependent granulocytic differentiation (Fig. 1) . The degree of phosphorylation of ATF2 by p38 kinase, which displayed ealier than the protein expression of ATF2, increased up to 4-fold (Fig. 6 ). To confirm these results further, the effect of the specific inhibitor of p38 , the pyridinyl imidazole derivative SB203580 on the granulocyte differentiation-induced phosphorylation of ATF-2 was examined. Since the SB203580 treatment almost blocked the differentiation procedure, it was not detected the phosphorylated ATF2 protein dependent on the differentiation (data not shown).
To further confirm that p38 kinase activation is involved in the RA response, we assayed for the activation of p38 kinase itself by phosphorylation of the kinase following RA treatment. Total cell extracts were prepared at the times indicated and assayed for expression and phosphorylation of p38 kinase. As shown in Fig. 6 , although p38 kinase expression levels do not change, its phosphorylation state increased from 1 day after RA treatment. This time course correlates with the phosphorylation of ATF2 as shown in Fig. 6 . Hence, these data provide direct evidence that RA stimulation leads to p38 kinase activation and ATF2
phosphorylation, potentiating the transactivation activity of ATF2.
RA treatment and p38 expression increases ATF2 transactivation by ASC-2 and the protein interaction of ATF2 and ASC-2 in vivo
To further characterize the functional meaning of ATF2 phosphorylation by p38 kinase, we examined the effects of p38 on the ASC-2-stimulated transactivation of ATF2-dependent reporter gene. U937cells were transiently transfected with plasmids encoding ATF2, p38 , p38 m and/or the coactivator ASC-2, along with CREreporter plasmid. Ectopic expression of p38 alone did not significantly increase the ATF2-dependent transactivation (Fig. 7A) . Interestingly, additional expression of ATF2 with p38 synergistically enhanced the ATF2-driven transactivation approximately 6-fold relative to transfection of p38 alone (Fig. 7A ). Compared to this increased fold effect of co-transfection of ATF2 and ASC-2, p38 contributed a highly enhanced activation of ATF2-driven transcription. RA treatment significantly increased the ATF2-ASC-2-driven transactivation, but the p38 m kinase expression inhibited the enhanced transactivation activity as shown in Fig. 7A . In addition to this, the p38 kinase specific inhibitor, SB203580, also blocked the RA-mediated transactivation by ATF2 and ASC-2 synergistic manner. These results suggest that the granulocytic differentiation by RA activates the p38 kinase pathway followed by increasing ATF2-ASC-2-mediated transactivation.
As previous results, RA treatment and constitutive active p38 expression led to increase the synergistic effect of ASC-2 on the transactivation function of ATF2.
This raises the possibility that ATF2 efficiently associates with ASC-2 dependent on extracelluar and endogeneous signals. The mammalian two-hybrid assay has been used extremely effectively to study protein-protein interactions in a variety of ways.
To verify it, we applied to use mammalian two-hybrid assay using GAL4-ATF2 and VP16-ASC-2 expression plasmids in the presence or absence of RA treatment or p38 overexpression. As shown in Fig. 7B , the molecular interaction of ATF2 and ASC-2 was enhanced by RA treatment. Since we postulated that p38 signaling pathway mediates RA-induced ATF2 transactivation, the effect of p38 expression on the protein interaction was examined by similar experiments. The transient transfection of p38 expression plasmids increased efficiently the molecular interaction of GAL4-ATF2 and VP16-ASC-2 in mammalian two-hybrid assay. As predicted, SB203580, specific inhibitor of p38 kinase, inhibited both RA treatment and p38 expression-induced protein interaction of ATF2 and ASC-2. These results suggest that RA enhances the protein interaction between ATF2 and ASC-2 through p38 kinase-mediated phosphorylation of ASC-2.
Dominant negative mutant ATF2, ASC-2 and p38 expression inhibits the induction of graulocytic differentiation
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To study the physiological role of ATF2, we generated U937 cell lines that express the wild-type ATF2 and the dominant negative mutant ATF2 (ATF2-Nd), which is deleted with the ASC-2-binding domain and transactivation domain. All genes were expressed under the control of a constitutive promoter. After selection with neomycin, cells were induced to differentiate. Immunoblot analysis revealed that two ATF2 constructs were expressed in transfected U937 cells, but absent in untransfected cells (Fig. 8A) . Cells expressing the wild-type ATF2 were able to produce Mac-1 protein (Fig. 8A) . ATF2-Nd expression inhibited the induction of late markers of granulocytic differentiation, Mac-1. The differentiation status correlated well with expression levels of ATF2. We also confirmed the interaction of ATF2 and ASC-2
was not detected in the ATF2-Nd expressing U937 cells (Fig. 8A) . When clones expressing wild-type ATF2 highly were treated with RA, they likewise underwent granulopoietic development, as assessed by detection of respiratory burst activity with nitroblue tetrazolium (NBT), with approximately 95% of the cells staining positively for NBT (Fig. 7C) , suggesting that the ATF2 overexpression is sufficient to mediate granulopoiesis induced by RA. In marked contrast, when the ATF2-Nd expression was unable to induce granulopoiesis (Fig. 7C) . In this case, only 22% of the cells were positive upon NBT staining in RA-treated cell fraction. Taken together, these results indicate that ATF2 is a positive regulator of granulocytic differentiation.
In addtition to the functional identification of ATF2, we next addressed the effect of ASC-2 and p38 kinase on RA-derived granulocytic differentiation by using dominant negative mutants of these two proteins. As shown in 
